Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 54   

Articles published

AZN 4,081.89 +48.39 (1.20%)
price chart
AstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents Expire
Feb. 2 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second-biggest drugmaker, fell the most in five months after saying profit this year will decline as the company prepares to face generic competition to top-selling medicines.
AstraZeneca Plans to Cut 7300 Jobs  Wall Street Journal
AstraZeneca closing Montreal R&D plant  Globe and Mail
Europe Job Losses Accelerate With AstraZeneca-to-PepsiCo Firing Employees
Global companies from NEC Corp. to PepsiCo Inc. and AstraZeneca Plc are chopping jobs more than three times faster than in 2011 as they brace for recession in Europe and a slowdown in China.
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents
Feb. 9 (Bloomberg) -- AstraZeneca Plc lost a U.S. appeals court bid to protect its best-selling drug, Crestor, from generic competition until as late as 2021.
Making the right exit: Lessons learned from AstraZeneca and IBM
The MSA also contained an obligation on AstraZeneca to produce an IT transfer plan for IBM detailing how the services would be transferred away from IBM.
Astra takes brand cancer drug straight to patients
AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.
Pharma seeks to ease pain of euro crisis
Simon Lowth, chief financial officer at AstraZeneca, echoes several peers when he argues that the situation eased when Greece paid off much outstanding debt in 2010 in the form of sovereign bonds.
Greek Doctors Battle Hospital Superbug
The drug-resistant K. pneumoniae bacteria have a genetic mutation that allows them to evade such powerful drugs as AstraZeneca Plc's Merrem and Johnson & Johnson's Doribax. A 2010 survey found 49 percent of K. pneumoniae samples in Greece aren't ...
A buy-out man who bought in
During his time at Investor AB he absorbed the culture and management style of the Wallenberg dynasty of investors, bankers and philanthropists that dates back to the 19th century and owns stakes in companies such as ABB, AstraZeneca, Electrolux and ...
GSK empties accounts to limit euro exposure
No numbers were disclosed, but the increase comes at a time other companies including AstraZeneca and Pfizer have been cutting UK employees.
GSK's DPU Scoreboard: Three Fewer, Four More -- But That Misses The Point  The IN VIVO Blog (blog)
Reckitt Benckiser shares boosted by outperformance
Shares in Reckitt Benckiser () moved higher as markets responded to its announcement that it had exceeded full-year targets for 2011 and posted a strategy to continue outperformance into 2012.